Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges
Journal of Medicinal Chemistry · 28.12.2023 · 66 (24) · 16546-16567
DOI: 10.1021/acs.jmedchem.3c01459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 12.12.2023. Verfasst von Qingqiang Min und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Science, Soochow Univer…. Hauptthemen laut MEDLINE: Prodrugs. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Time- and space-resolved drug delivery is highly demanded for cancer treatment, which, however, can barely be achieved with a traditional prodrug strategy. In recent years, the prodrug strategy based on a bioorthogonal bond cleavage chemistry has emerged with the advantages of high temporospatial resolution over drug activation and homogeneous activation irrespective of individual heterogeneity. In the past five years, tremendous progress has been witnessed in this field with one such bioorthogonal prodrug entering Phase II clinical trials. This Perspective aims to highlight these new advances (2019-2023) and critically discuss their pros and cons. In addition, the remaining challenges and potential strategic directions for future progress will also be included.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.
ORCID-Profile: Xingyue Ji
Förderung
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Min, Q., & Ji, X. (2023). Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges. Journal of Medicinal Chemistry, 66(24), 16546-16567. https://doi.org/10.1021/acs.jmedchem.3c01459
Vancouver
Min Q, Ji X. Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges. Journal of Medicinal Chemistry. 2023;66(24):16546-16567. doi:10.1021/acs.jmedchem.3c01459
BibTeX
@article{Min2023,
author = {Min, Qingqiang and Ji, Xingyue},
title = {Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {24},
pages = {16546--16567},
doi = {10.1021/acs.jmedchem.3c01459}
}
EUVIMED